Literature DB >> 19224314

Acquired hepatocerebral degeneration.

Joseph Ferrara1, Joseph Jankovic.   

Abstract

Cirrhosis and its co-morbidities may cause a variety of neurological complications, the most common being bouts of toxic metabolic encephalopathy. A proportion of patients with chronic liver disease develop acquired hepatocerebral degeneration (AHD), a chronic progressive neurological syndrome characterized by parkinsonism, ataxia and other movement disorders. This article reviews the clinical spectrum, pathophysiology, neuroimaging features and differential diagnosis of AHD along with emerging treatment options.

Entities:  

Mesh：

Year:  2009        PMID： 19224314     DOI： 10.1007/s00415-009-0144-7

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


  154 in total

1.  Hereditary hemorrhagic telangiectasia. A case with hepatocellular carcinoma and acquired hepatocerebral degeneration.

Authors:  E B Sussman; S S Sternberg
Journal:  Arch Pathol       Date:  1975-02

2.  Clinical significance of extrapyramidal signs in patients with cirrhosis.

Authors:  Rodrigo Jover; Luís Compañy; Ana Gutiérrez; Macarena Lorente; Pedro Zapater; María J Poveda; José Such; Sonia Pascual; José M Palazón; Fernando Carnicer; Francisco Ferrandis; Miguel Pérez-Mateo
Journal:  J Hepatol       Date:  2005-05       Impact factor: 25.083

3.  Manganese deposition in basal ganglia structures results from both portal-systemic shunting and liver dysfunction.

Authors:  C Rose; R F Butterworth; J Zayed; L Normandin; K Todd; A Michalak; L Spahr; P M Huet; G Pomier-Layrargues
Journal:  Gastroenterology       Date:  1999-09       Impact factor: 22.682

Review 4.  Manganese neurotoxicity: a focus on the neonate.

Authors:  Keith M Erikson; Khristy Thompson; Judy Aschner; Michael Aschner
Journal:  Pharmacol Ther       Date:  2006-09-22       Impact factor: 12.310

5.  Manganese deposition in the globus pallidus in patients with biliary atresia.

Authors:  S Ikeda; Y Yamaguchi; Y Sera; H Ohshiro; S Uchino; Y Yamashita; M Ogawa
Journal:  Transplantation       Date:  2000-06-15       Impact factor: 4.939

Review 6.  Manganese neurotoxicity.

Authors:  Allison W Dobson; Keith M Erikson; Michael Aschner
Journal:  Ann N Y Acad Sci       Date:  2004-03       Impact factor: 5.691

7.  Pattern and course of neurodegeneration in Langerhans cell histiocytosis.

Authors:  Martha Wnorowski; Helmut Prosch; Daniela Prayer; Gisela Janssen; Helmut Gadner; Nicole Grois
Journal:  J Pediatr       Date:  2008-02-11       Impact factor: 4.406

8.  Manganese and chronic hepatic encephalopathy.

Authors:  D Krieger; S Krieger; O Jansen; P Gass; L Theilmann; H Lichtnecker
Journal:  Lancet       Date:  1995-07-29       Impact factor: 79.321

9.  Corticospinal involvement in patients with a portosystemic shunt due to liver cirrhosis: a MEP study.

Authors:  Raffaele Nardone; Thomas Buratti; Antonio Oliviero; Andreas Lochmann; Frediano Tezzon
Journal:  J Neurol       Date:  2005-08-04       Impact factor: 6.682

10.  Clinical correlation of brain MRI and MRS abnormalities in patients with Wilson disease.

Authors:  R A Page; C A Davie; D MacManus; K A Miszkiel; J M Walshe; D H Miller; A J Lees; A H V Schapira
Journal:  Neurology       Date:  2004-08-24       Impact factor: 9.910
View more
  20 in total

Review 1.  Neurologic complications after liver transplantation.

Authors:  Saša A Zivković
Journal:  World J Hepatol       Date:  2013-08-27

2.  Parkinsonian syndrome and ataxia as a presenting finding of acquired hepatocerebral degeneration.

Authors:  Vladimir Miletić; David Ozretić; Maja Relja
Journal:  Metab Brain Dis       Date:  2014-01-05       Impact factor: 3.584

Review 3.  Challenges in diagnosing hepatic encephalopathy.

Authors:  K Weissenborn
Journal:  Neurochem Res       Date:  2014-08-21       Impact factor: 3.996

Review 4.  Movement Disorders in Metabolic Disorders.

Authors:  José Luiz Pedroso; Orlando G Barsottini; Alberto J Espay
Journal:  Curr Neurol Neurosci Rep       Date:  2019-02-09       Impact factor: 5.081

5.  Syndrome of hepatic cirrhosis, dystonia, polycythemia, and hypermanganesemia caused by mutations in SLC30A10, a manganese transporter in man.

Authors:  Karin Tuschl; Peter T Clayton; Sidney M Gospe; Shamshad Gulab; Shahnaz Ibrahim; Pratibha Singhi; Roosy Aulakh; Reinaldo T Ribeiro; Orlando G Barsottini; Maha S Zaki; Maria Luz Del Rosario; Sarah Dyack; Victoria Price; Andrea Rideout; Kevin Gordon; Ron A Wevers; W K Kling Chong; Philippa B Mills
Journal:  Am J Hum Genet       Date:  2012-02-16       Impact factor: 11.025

6.  Acquired hepatocerebral degeneration: A case report.

Authors:  Clarice Listik; Gislaine Cristina Lopes Machado-Porto; Maira Okada de Oliveira; Fábio Henrique de Gobbi Porto
Journal:  Dement Neuropsychol       Date:  2012 Jan-Mar

7.  Chronic acquired hepatocerebral degeneration, pallidal T1 MRI hyperintensity and manganese in a series of cirrhotic patients.

Authors:  Elisa Maffeo; Anna Montuschi; Guido Stura; Maria Teresa Giordana
Journal:  Neurol Sci       Date:  2013-05-28       Impact factor: 3.307

Review 8.  Neurologic manifestations of gastrointestinal and liver diseases.

Authors:  José M Ferro; Sofia Oliveira
Journal:  Curr Neurol Neurosci Rep       Date:  2014-10       Impact factor: 5.081

9.  Chronic acquired hepatocerebral degeneration presenting with Meige's syndrome and behavioral symptoms fully reversed by liver transplantation.

Authors:  Andrea Stracciari; Luca Spinardi; Maria Guarino
Journal:  Neurol Sci       Date:  2021-07-19       Impact factor: 3.307

10.  Cerebellar ataxia and neuropathy as presenting features of hepatitis-B related cirrhosis and portal hypertension.

Authors:  Arunmozhi Elavarasi; Deepa Dash; Manjari Tripathi; Rohit Bhatia
Journal:  BMJ Case Rep       Date:  2017-10-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.